These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 20521362)

  • 1. Cyclosporine after MI.
    King A
    Nat Rev Cardiol; 2010 Jun; 7(6):302. PubMed ID: 20521362
    [No Abstract]   [Full Text] [Related]  

  • 2. An integrated safety profile analysis of belatacept in kidney transplant recipients.
    Grinyó J; Charpentier B; Pestana JM; Vanrenterghem Y; Vincenti F; Reyes-Acevedo R; Apanovitch AM; Gujrathi S; Agarwal M; Thomas D; Larsen CP
    Transplantation; 2010 Dec; 90(12):1521-7. PubMed ID: 21088650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of Remuscularization Following Transplantation of Human Embryonic Stem Cell-Derived Cardiovascular Progenitor Cells in Infarcted Nonhuman Primates.
    Zhu K; Wu Q; Ni C; Zhang P; Zhong Z; Wu Y; Wang Y; Xu Y; Kong M; Cheng H; Tao Z; Yang Q; Liang H; Jiang Y; Li Q; Zhao J; Huang J; Zhang F; Chen Q; Li Y; Chen J; Zhu W; Yu H; Zhang J; Yang HT; Hu X; Wang J
    Circ Res; 2018 Mar; 122(7):958-969. PubMed ID: 29343525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Belatacept-based regimens are associated with improved cardiovascular and metabolic risk factors compared with cyclosporine in kidney transplant recipients (BENEFIT and BENEFIT-EXT studies).
    Vanrenterghem Y; Bresnahan B; Campistol J; Durrbach A; Grinyó J; Neumayer HH; Lang P; Larsen CP; Mancilla-Urrea E; Pestana JM; Block A; Duan T; Glicklich A; Gujrathi S; Vincenti F
    Transplantation; 2011 May; 91(9):976-83. PubMed ID: 21372756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NFATc3-induced reductions in voltage-gated K+ currents after myocardial infarction.
    Rossow CF; Minami E; Chase EG; Murry CE; Santana LF
    Circ Res; 2004 May; 94(10):1340-50. PubMed ID: 15087419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcineurin inhibition ameliorates structural, contractile, and electrophysiologic consequences of postinfarction remodeling.
    Deng L; Huang B; Qin D; Ganguly K; El-Sherif N
    J Cardiovasc Electrophysiol; 2001 Sep; 12(9):1055-61. PubMed ID: 11573696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical effects of cyclosporine A on reperfusion injury in myocardial infarction: a meta-analysis of randomized controlled trials.
    Yingzhong C; Lin C; Chunbin W
    Springerplus; 2016; 5(1):1117. PubMed ID: 27478734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Safety of Cyclosporine in Acute Myocardial Infarction: A Systematic Review and Meta-Analysis.
    Rahman FA; Abdullah SS; Manan WZWA; Tan LT; Neoh CF; Ming LC; Chan KG; Lee LH; Goh BH; Salmasi S; Wu DB; Khan TM
    Front Pharmacol; 2018; 9():238. PubMed ID: 29970999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the calcineurin dependent signaling pathway inhibition by cyclosporin A on early and late cardiac remodeling following myocardial infarction.
    Youn TJ; Piao H; Kwon JS; Choi SY; Kim HS; Park DG; Kim DW; Kim YG; Cho MC
    Eur J Heart Fail; 2002 Dec; 4(6):713-8. PubMed ID: 12453541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brief postinfarction calcineurin blockade affects left ventricular remodeling and Ca2+ handling in the rat.
    Mackiewicz U; Maczewski M; Klemenska E; Brudek M; Konior A; Czarnowska E; Lewartowski B
    J Mol Cell Cardiol; 2010 Jun; 48(6):1307-15. PubMed ID: 20051247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Belatacept-based regimens versus a cyclosporine A-based regimen in kidney transplant recipients: 2-year results from the BENEFIT and BENEFIT-EXT studies.
    Larsen CP; Grinyó J; Medina-Pestana J; Vanrenterghem Y; Vincenti F; Breshahan B; Campistol JM; Florman S; Rial Mdel C; Kamar N; Block A; Di Russo G; Lin CS; Garg P; Charpentier B
    Transplantation; 2010 Dec; 90(12):1528-35. PubMed ID: 21076381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporine A in Reperfused Myocardial Infarction: The Multicenter, Controlled, Open-Label CYCLE Trial.
    Ottani F; Latini R; Staszewsky L; La Vecchia L; Locuratolo N; Sicuro M; Masson S; Barlera S; Milani V; Lombardi M; Costalunga A; Mollichelli N; Santarelli A; De Cesare N; Sganzerla P; Boi A; Maggioni AP; Limbruno U;
    J Am Coll Cardiol; 2016 Feb; 67(4):365-374. PubMed ID: 26821623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondria-targeted cyclosporin A delivery system to treat myocardial ischemia reperfusion injury of rats.
    Zhang CX; Cheng Y; Liu DZ; Liu M; Cui H; Zhang BL; Mei QB; Zhou SY
    J Nanobiotechnology; 2019 Jan; 17(1):18. PubMed ID: 30683110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-lymphocyte subsets in renal allograft recipients treated with cyclosporine and azathioprine.
    Sumpio BE; Dwyer JM; Flye MW
    Ann Surg; 1987 Jan; 205(1):49-53. PubMed ID: 3541801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospital-diagnosed atopic dermatitis and long-term risk of myocardial infarction: a population-based follow-up study.
    Riis JL; Vestergaard C; Hjuler KF; Iversen L; Jakobsen L; Deleuran MS; Olsen M
    BMJ Open; 2016 Nov; 6(11):e011870. PubMed ID: 27836869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticle-Mediated Targeting of Cyclosporine A Enhances Cardioprotection Against Ischemia-Reperfusion Injury Through Inhibition of Mitochondrial Permeability Transition Pore Opening.
    Ikeda G; Matoba T; Nakano Y; Nagaoka K; Ishikita A; Nakano K; Funamoto D; Sunagawa K; Egashira K
    Sci Rep; 2016 Feb; 6():20467. PubMed ID: 26861678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different effects of metabolic inhibitors and cyclosporin A on daunorubicin transport in leukemia cells from patients with AML.
    Knaust E; Porwit-MacDonald A; Gruber A; Xu D; Peterson C
    Leuk Res; 2003 Feb; 27(2):183-91. PubMed ID: 12526924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ischemia-reperfusion induces myocardial infarction through mitochondrial Ca²⁺ overload.
    Shintani-Ishida K; Inui M; Yoshida K
    J Mol Cell Cardiol; 2012 Aug; 53(2):233-9. PubMed ID: 22659291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized trial comparing cyclosporine induction with sequential therapy in renal transplant recipients.
    Kasiske BL; Johnson HJ; Goerdt PJ; Heim-Duthoy KL; Rao VK; Dahl DC; Ney AL; Andersen RC; Jacobs DM; Odland MD
    Am J Kidney Dis; 1997 Nov; 30(5):639-45. PubMed ID: 9370178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphine mimics the antiapoptotic effect of preconditioning via an Ins(1,4,5)P3 signaling pathway in rat ventricular myocytes.
    Barrère-Lemaire S; Combes N; Sportouch-Dukhan C; Richard S; Nargeot J; Piot C
    Am J Physiol Heart Circ Physiol; 2005 Jan; 288(1):H83-8. PubMed ID: 15345483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.